tiprankstipranks
Trending News
More News >
Ligand Pharma (LGND)
NASDAQ:LGND
US Market

Ligand Pharma (LGND) Cash flow

Compare
830 Followers

Ligand Pharma Cash Flow

LGND's free cash flow for Q3 2025 was $13.15M. For the 2025 fiscal year, LGND's free cash flow was decreased by $81.68M and operating cash flow was $13.16M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 97.05M$ 49.58M$ 137.85M$ 78.80M$ 54.59M
Investing Cash Flow
$ -143.66M$ -11.68M$ 163.62M$ 30.52M$ 231.65M
Financing Cash Flow
$ 97.14M$ -59.95M$ -275.99M$ -137.76M$ -310.55M
End Cash Position
$ 72.31M$ 22.95M$ 45.01M$ 19.52M$ 47.96M
Free Cash Flow
$ 77.41M$ -4.27M$ 119.93M$ 70.04M$ 50.13M
Currency in USD

Ligand Pharma Cash Flow